Journal of Clinical Pediatrics >
Analysis of the plasma amino acid spectrum of congenital bile acid synthesis disorder type 2
Received date: 2022-02-18
Online published: 2023-06-12
Objective To investigate the changes of plasma amino acid spectrum and its clinical significance in infants with CBAS2(congenital bile acid synthesis disorder type 2 ). Methods The clinical data of children with infantile cholestasis treated from January 2016 to June 2021 were retrospectively analyzed. According to the etiology, they were divided into CBAS2 group, neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD ) group and idiopathic neonatal intrahepatic hepatitis (INH) group. The differences of 22 amino acids in plasma among the three groups were compared. Results A total of 85 infantile cholestasis patients (58 boys and 27 girls) were included, and the median age was 2.3 (2.0-4.0) months. The median total bilirubin was 134.9 (103.1-181.7) μmol/L, and the median direct bilirubin was 79.0 (62.2-110.6) μmol/L. Among the 12 patients in CBAS2 group, 3 or more amino acids changed in 11 patients (91.7%) and branched chain amino acid (leucine, isoleucine and valine) was normal in 11 patients (91.7%). In the INH group, 17 (73.9%) of the 23 patients had≥3 amino acid changes. All the 50 patients in NICCD group had ≥3 amino acid changes. Compared with INH group, the levels of asparagine, serine, threonine and tyrosine in CBAS2 and NICCD groups were higher. Compared with NICCD group, the levels of glutamine, alanine, tryptophan, leucine and alanine/citrulline were higher, while the levels of citrulline, arginine, methionine, basic amino acid and threonine/serine were lower in CBAS2 group, and the differences were statistically significant (P<0.05). Conclusions Plasma amino acid spectra in children with CBAS2 vary widely. The changes of plasma amino acid spectra in CBAS2 children are different from those in NICCD and INH children, which is of great significance for the diagnosis and differential diagnosis of CBAS2.
Lanhui SHE , Xufang LI , Jiawei YE , Limei TAN , Huamei YANG , Chunxiao FANG , Kaili LIAO , Yi XU . Analysis of the plasma amino acid spectrum of congenital bile acid synthesis disorder type 2[J]. Journal of Clinical Pediatrics, 2023 , 41(6) : 470 -474 . DOI: 10.12372/jcp.2023.22e0229
[1] | Chen JY, Wu JF, Kimura A, et al. AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: possibly underdiagnosed diseases[J]. Pediatr Neonatol, 2020, 61(1): 75-83. |
[2] | Jin Y, Chen M, Penning TM. Rate of steroid double-bond reduction catalysed by the human steroid 5β-reductase (AKR1D1) is sensitive to steroid structure: implications for steroid metabolism and bile acid synthesis[J]. Biochem J, 2014, 462(1): 163-171. |
[3] | Appanna N, Gibson H, Gangitano E, et al. Differential activity and expression of human 5β-reductase (AKR1D1) splice variants[J]. J Mol Endocrinol, 2021, 66(3): 181-194. |
[4] | Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition[J]. J Pediatr Gastroenterol Nutr, 2004, 39(2): 115-128. |
[5] | Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis[J]. J Med Virol, 2020, 92(4): 418-423.. |
[6] | 张占卿, 张丽军. 血浆氨基酸模式诊断慢性肝炎疾病状态的研究现状[J]. 临床荟萃, 2009, 24(9): 816-818. |
[7] | 沈耕荣, 余书文, 董祥家, 等. 重症肝炎[M]. 天津: 天津科技出版社, 1990. |
[8] | 佘兰辉, 李旭芳, 叶家卫, 等. 先天性胆汁酸合成障碍2型8例临床特征及基因变异分析[J]. 临床儿科杂志, 2020, 38(12): 936-939. |
/
〈 |
|
〉 |